A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose bladder ...

RNA vaccines, which have proved effective against COVID-19, are now being developed for many other diseases, including cancer ...

Abogen Biosciences ("Abogen" or the "Group"), a clinical-stage biotechnology group pioneering RNA innovation, announced that ...

RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles ...

Uncover the latest and most impactful research in RNA Structure Prediction and Analysis. Explore pioneering discoveries, insightful ideas and new methods from leading researchers in the field. Much of ...

Novartis (NYSE:NVS) has entered into a licensing agreement with Chinese biotechnology company Abogen covering an experimental RNA-based therapy and other potential treatments developed using Abogen’s ...

Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer TherapeuticsOversubscribed round led by 4BIO Capital includes ...

Scientists may have found a clue to one of the biggest mysteries surrounding the origin of life: how fragile RNA molecules could gather and survive before cells existed. New research shows that RNA is ...

Although there are striking differences between the cells that make up your eyes, kidneys, brain and toes, the DNA blueprint for these cells is essentially the same. Where do those differences come ...

GLP-1 drugs have revolutionized obesity treatment, but they can lead people to lose muscle mass along with fat. And when ...

Cross-kingdom RNA interference (RNAi) is a key virulence mechanism in which pathogens deliver small RNAs (sRNAs) into host plants, hijacking host ARGONAUTE (AGO) proteins to silence immunity-related ...

Automation, enzymatic synthesis and integrated services can cut costs, speed turnaround and capture demand from RNA therapeutics, NGS and CRISPR.Dublin, Oct. 02, 2026 (GLOBE NEWSWIRE) -- ...